Summary & Overview
HCPCS G0516: Insertion of 4+ Non-biodegradable Subdermal Drug-Delivery Implants
HCPCS Level II code G0516 designates the insertion of four or more non-biodegradable subdermal drug-delivery implants. This code captures a specific minor surgical procedure used to place multiple subdermal rods that deliver medication over time, and it is relevant for outpatient clinics and ambulatory surgical centers across the United States. Nationally, accurate use of this code affects claims processing, coding compliance, and aggregated utilization reporting for implant-based drug delivery therapies.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, typical sites of service, and the administrative components tied to billing this service. The publication summarizes benchmark considerations and common billing modifiers used with this type of service. It also highlights areas where payers commonly apply coverage rules or prior authorization, and where coding specificity matters for claims adjudication.
This summary is intended to orient clinicians, coding professionals, and policy analysts to the purpose and billing context of G0516, and to indicate the kinds of benchmarks and policy updates that impact national reimbursement and utilization monitoring for multi-implant subdermal drug delivery procedures.
Billing Code Overview
HCPCS Level II code G0516 describes insertion of non-biodegradable drug delivery implants, four or more, typically used for subdermal rod implant procedures. The service type is insertion of multiple subdermal drug-delivery implants, and the typical site of service is an outpatient clinic or ambulatory surgical center where minor surgical implant procedures are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A premenopausal 32-year-old patient presents to an ambulatory surgical center requesting long-acting reversible contraception. After counseling, the clinician schedules insertion of four or more subdermal non-biodegradable rod implants placed in the upper arm under local anesthesia. On the day of service the patient undergoes verification of informed consent, sterile prep, local anesthesia (e.g., lidocaine), placement of four separate rod implants using the manufacturer's inserter, wound dressing, and post-procedure observation for bleeding or vasovagal reaction. Typical workflow includes check-in and medical-history review, confirmation of pregnancy status if indicated, procedure consent, procedure documentation including implant lot numbers, patient education on implant site care and removal timeline, and scheduling of follow-up or removal visit. Typical sites of service are outpatient clinic procedure rooms, ambulatory surgery centers, or physician offices with minor procedure capability.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier; standard reporting | Use when billing the primary service without special circumstances |
11 | Default/primary procedure |